chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Product administered to patient of inappropriate age
Clinical narrative: Unspecifies side effects; under age of 18; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT (Unspecifies side effects) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age of 18) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age of 18). On an unknown date, the patient experienced ADVERSE EVENT (Unspecifies side effects). At the time of the report, ADVERSE EVENT (Unspecifies side effects) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under age of 18) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Positive covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid-19) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COVID-19 (Positive covid-19). At the time of the report, COVID-19 (Positive covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site swelling
Clinical narrative: Hard lump at the injection site; Ache at injection site; Swollen; Red; Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard lump at the injection site), VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PAIN (Painful) and VACCINATION SITE PAIN (Ache at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PAIN (Painful). On 25-Apr-2021, the patient experienced VACCINATION SITE MASS (Hard lump at the injection site) and VACCINATION SITE PAIN (Ache at injection site). On 18-Apr-2021, VACCINATION SITE SWELLING (Swollen), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PAIN (Painful) had resolved. At the time of the report, VACCINATION SITE MASS (Hard lump at the injection site) and VACCINATION SITE PAIN (Ache at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication was not provided.  The treatment information was not provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Hyperhidrosis, Memory impairment, Pain in extremity
Clinical narrative: sweating; chills/shivering; Shivering; low grade fever; Feels confused; memory issues; Pain in Left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating) and CHILLS (chills/shivering) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in Left arm). On 23-Apr-2021, the patient experienced CONFUSIONAL STATE (Feels confused) and MEMORY IMPAIRMENT (memory issues). On 24-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Relevant concomitant medications included Birth control pills.  Treatment information was not provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: sweating; chills/shivering; Shivering; low grade fever; Feels confused; memory issues; Pain in Left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating) and CHILLS (chills/shivering) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in Left arm). On 23-Apr-2021, the patient experienced CONFUSIONAL STATE (Feels confused) and MEMORY IMPAIRMENT (memory issues). On 24-Apr-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in Left arm), CONFUSIONAL STATE (Feels confused), MEMORY IMPAIRMENT (memory issues), HYPERHIDROSIS (sweating), CHILLS (chills/shivering), CHILLS (Shivering) and PYREXIA (low grade fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Relevant concomitant medications included Birth control pills.  Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Muscle twitching, Pulse abnormal
Clinical narrative: Muscle twitching in right arm/ Twitching all over body; Pulsing kind of sensation; Inappropriate schedule of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Muscle twitching in right arm/ Twitching all over body), PULSE ABNORMAL (Pulsing kind of sensation) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 002B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Hypertension, LEVOTHYROXINE SODIUM from 07-Apr-2021 to an unknown date for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced MUSCLE TWITCHING (Muscle twitching in right arm/ Twitching all over body). 22-Apr-2021, the patient experienced PULSE ABNORMAL (Pulsing kind of sensation) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine). At the time of the report, MUSCLE TWITCHING (Muscle twitching in right arm/ Twitching all over body) and PULSE ABNORMAL (Pulsing kind of sensation) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine) had resolved. Not Provided          No treatment details were added.  Patient reported that the symptoms started 5 minute after the second shot. Twitching spreaded to stomach, arms, legs on the night. During day it was more and during night less.  Levothyroxine was indicated for thyroid.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Patient demographics added, added details of concomitant medications, adverse event details and outcome of the event updated
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: rash had spread, nowpatches on both legs front and back that stay under control as long as she takes medicine; painful rash/ patches on both legs; shingles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (painful rash/ patches on both legs), HERPES ZOSTER (shingles) and RASH (rash had spread, nowpatches on both legs front and back that stay under control as long as she takes medicine) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced RASH (painful rash/ patches on both legs) and HERPES ZOSTER (shingles). On 19-Apr-2021, the patient experienced RASH (rash had spread, nowpatches on both legs front and back that stay under control as long as she takes medicine). At the time of the report, RASH (painful rash/ patches on both legs), HERPES ZOSTER (shingles) and RASH (rash had spread, nowpatches on both legs front and back that stay under control as long as she takes medicine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided treatment medication included anti-viral medications.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Mobility decreased, Pain in extremity, Pyrexia
Clinical narrative: limited mobility of left arm; pain; Fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (limited mobility of left arm), PAIN IN EXTREMITY (pain), PYREXIA (Fever), CHILLS (chills) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus and Hypertension. Concomitant products included METFORMIN for Diabetes mellitus, LISINOPRIL for Hypertension.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced MOBILITY DECREASED (limited mobility of left arm), PAIN IN EXTREMITY (pain), PYREXIA (Fever), CHILLS (chills) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of Unknown. On 15-Apr-2021, PYREXIA (Fever) and CHILLS (chills) had resolved. At the time of the report, MOBILITY DECREASED (limited mobility of left arm), PAIN IN EXTREMITY (pain) and FATIGUE (fatigue) was resolving.            The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable      Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: follow up doc attached on 19 JUL 2021 in which outcome is updated to resolving.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Myalgia, Palpitations, Panic reaction
Clinical narrative: every muscle in her body ached; heart palpitations/rapid heartbeat; panicked; Cough; This spontaneous case was reported by a consumer and describes the occurrence of PANIC REACTION (panicked), COUGH (coughing like crazy, not deep in chest-more like got caught in a sand storm), PALPITATIONS (heart palpitations/rapid heartbeat) and MYALGIA (every muscle in her body ached) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatic disorder and Palpitation.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced COUGH (coughing like crazy, not deep in chest-more like got caught in a sand storm). On 02-Apr-2021, the patient experienced PANIC REACTION (panicked) and PALPITATIONS (heart palpitations/rapid heartbeat). On 03-Apr-2021, the patient experienced MYALGIA (every muscle in her body ached). On 02-Apr-2021, PANIC REACTION (panicked), COUGH (coughing like crazy, not deep in chest-more like got caught in a sand storm) and PALPITATIONS (heart palpitations/rapid heartbeat) had resolved. At the time of the report, MYALGIA (every muscle in her body ached) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. The patient took a herb called "Hawthorn" and the palpitations were relieved.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Malaise, Myalgia
Clinical narrative: Malaise; fever; nausea; vomiting; headache; bodyache, muscle pain; chills; lump at vaccination site; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was reported.  The patient's past medical history included No adverse event. Concomitant products included chemotherapy                                                   for breast cancer for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced MALAISE (Malaise), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), MYALGIA (bodyache, muscle pain), CHILLS (chills), VACCINATION SITE MASS (lump at vaccination site) and ARTHRALGIA (joint pain). At the time of the report, MALAISE (Malaise), PYREXIA (fever), VOMITING (vomiting), HEADACHE (headache), MYALGIA (bodyache, muscle pain), CHILLS (chills), VACCINATION SITE MASS (lump at vaccination site) and ARTHRALGIA (joint pain) had not resolved and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-091897 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site mass, Vomiting
Clinical narrative: Malaise; fever; nausea; vomiting; headache; bodyache, muscle pain; chills; lump at vaccination site; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was reported.  The patient's past medical history included No adverse event. Concomitant products included chemotherapy                                                   for breast cancer for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced MALAISE (Malaise), PYREXIA (fever), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), MYALGIA (bodyache, muscle pain), CHILLS (chills), VACCINATION SITE MASS (lump at vaccination site) and ARTHRALGIA (joint pain). At the time of the report, MALAISE (Malaise), PYREXIA (fever), VOMITING (vomiting), HEADACHE (headache), MYALGIA (bodyache, muscle pain), CHILLS (chills), VACCINATION SITE MASS (lump at vaccination site) and ARTHRALGIA (joint pain) had not resolved and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-091897 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Rhinorrhoea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rhinorrhea (runny nose), nasopharyngitis (cold-like symptoms), rhinorrhea (snotty) and pyrexia (fever that "broke") in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 046A21A) for COVID-19 immunization. No medical history reported. On Apr 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 25, 2021, patient experienced rhinorrhea (runny nose), nasopharyngitis (cold-like symptoms), rhinorrhea (snotty) and pyrexia (fever that "broke"). At the time of the report, rhinorrhea (runny nose), nasopharyngitis (cold-like symptoms), rhinorrhea (snotty) and pyrexia (fever that "broke") outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant product information not provided. Treatment included cold medication, tea, honey and ginger. Patient stated she does not think she has COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Swelling in bottom lip in corner occurred 3 hours after Moderna Vaccination; This spontaneous case was reported by a pharmacist and describes the occurrence of LIP SWELLING (Swelling in bottom lip in corner occurred 3 hours after Moderna Vaccination) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE for an unknown indication.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced LIP SWELLING (Swelling in bottom lip in corner occurred 3 hours after Moderna Vaccination). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, LIP SWELLING (Swelling in bottom lip in corner occurred 3 hours after Moderna Vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (arm is sore). At the time of the report, LIMB DISCOMFORT (arm is sore) outcome was unknown. Not Provided          No concomitant medications were provided No treatment medications were provided
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Joint swelling, Tongue exfoliation
Clinical narrative: Swollen ankles; High Blood Pressure; Peeling Tongue; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE EXFOLIATION (Peeling Tongue), JOINT SWELLING (Swollen ankles) and BLOOD PRESSURE INCREASED (High Blood Pressure) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Diabetes.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced TONGUE EXFOLIATION (Peeling Tongue). On 23-Apr-2021, the patient experienced JOINT SWELLING (Swollen ankles) and BLOOD PRESSURE INCREASED (High Blood Pressure). At the time of the report, TONGUE EXFOLIATION (Peeling Tongue), JOINT SWELLING (Swollen ankles) and BLOOD PRESSURE INCREASED (High Blood Pressure) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medication information were Diuretic, Cetirizine provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: pt is fine. declined further follow up
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Fatigue; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a non-health professional and describes the occurrence of FATIGUE (Fatigue) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (Fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 2 dosage form. On 05-Mar-2021, FATIGUE (Fatigue) and HEADACHE (headache) had resolved. Not Provided          No specific treatment information for these events was provided by the reporter      Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Non-Significant follow up appended to AER
Sex: U
Vaccine: COVID19
Symptoms: Bedridden
Clinical narrative: Cancer patient was laid out for 2 weeks; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (Cancer patient was laid out for 2 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (Cancer patient was laid out for 2 weeks). At the time of the report, BEDRIDDEN (Cancer patient was laid out for 2 weeks) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-091960 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-091960:Same reporter, different patient
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Cold sweat, Decreased appetite, Feeling abnormal, Myalgia
Clinical narrative: loss his sense of smell; Pains; fever; body ache; loss of appetite; felt awful,; cold sweats; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), ANOSMIA (loss his sense of smell) and PAIN (Pains) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), PAIN (Pains), PYREXIA (fever) and MYALGIA (body ache). On 26-Apr-2021, the patient experienced ANOSMIA (loss his sense of smell). The patient was treated with PARACETAMOL (TYLENOL) from 23-Apr-2021 to 24-Apr-2021 at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), ANOSMIA (loss his sense of smell), PAIN (Pains), PYREXIA (fever) and MYALGIA (body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant details were provided
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: loss his sense of smell; Pains; fever; body ache; loss of appetite; felt awful,; cold sweats; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), ANOSMIA (loss his sense of smell) and PAIN (Pains) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), PAIN (Pains), PYREXIA (fever) and MYALGIA (body ache). On 26-Apr-2021, the patient experienced ANOSMIA (loss his sense of smell). The patient was treated with PARACETAMOL (TYLENOL) from 23-Apr-2021 to 24-Apr-2021 at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (felt awful,), COLD SWEAT (cold sweats), ANOSMIA (loss his sense of smell), PAIN (Pains), PYREXIA (fever) and MYALGIA (body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant details were provided
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash
Clinical narrative: Headaches; Bad rash on stomach and back for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Bad rash on stomach and back for 2 days) and HEADACHE (Headaches) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Bad rash on stomach and back for 2 days) and HEADACHE (Headaches). At the time of the report, RASH (Bad rash on stomach and back for 2 days) and HEADACHE (Headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Events outcome updated from unknown to recovered/resolved.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 100.2; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.2) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.2). At the time of the report, PYREXIA (Fever of 100.2) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) 100.2.         Concomitant medication include blood pressure medication.  Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling
Clinical narrative: arm swelled up in her muscles for 4-5 days; sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up in her muscles for 4-5 days) and MYALGIA (sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm swelled up in her muscles for 4-5 days) and MYALGIA (sore). At the time of the report, PERIPHERAL SWELLING (arm swelled up in her muscles for 4-5 days) and MYALGIA (sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  The patient was treated with cold pack with no relief.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: slight fever (99.3 F); chills and other stuff; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (slight fever (99.3 F)) and CHILLS (chills and other stuff) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     The patient's past medical history included Lung cancer (two years ago). Concomitant products included ENTRECTINIB (ROZLYTREK) for Lung cancer, APIXABAN (ELIQUIS) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PYREXIA (slight fever (99.3 F)) and CHILLS (chills and other stuff). At the time of the report, PYREXIA (slight fever (99.3 F)) and CHILLS (chills and other stuff) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 99.3 (High) increased 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Non drug treatment included radiation therapy and chemotherapy Patient was Eliquis as a use of blood thinner. Patient height was given as 5'11"
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature abnormal, Chills, Pain in extremity, Toothache
Clinical narrative: Tooth ache; Sore arm; Couldn't regulate body temperature; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Tooth ache), PAIN IN EXTREMITY (Sore arm), BODY TEMPERATURE ABNORMAL (Couldn't regulate body temperature) and CHILLS (Chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included INSULIN, DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF), MECLIZINE HCL, HYDROXYZINE and MORPHINE for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced TOOTHACHE (Tooth ache), PAIN IN EXTREMITY (Sore arm), BODY TEMPERATURE ABNORMAL (Couldn't regulate body temperature) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), BODY TEMPERATURE ABNORMAL (Couldn't regulate body temperature) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication includes blood pressure medication
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed dosing window of second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed dosing window of second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dosing window of second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed dosing window of second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Decreased appetite, Influenza like illness, Nasopharyngitis
Clinical narrative: Had a cold; lost his appetite; started losing sense of taste \ couldn't taste anything; started losing sense of smell; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (started losing sense of taste \ couldn't taste anything), ANOSMIA (started losing sense of smell), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (Had a cold) and DECREASED APPETITE (lost his appetite) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 23-Apr-2021, the patient experienced AGEUSIA (started losing sense of taste \ couldn't taste anything), ANOSMIA (started losing sense of smell), INFLUENZA LIKE ILLNESS (flu-like symptoms) and DECREASED APPETITE (lost his appetite). On 25-Apr-2021, the patient experienced NASOPHARYNGITIS (Had a cold). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, AGEUSIA (started losing sense of taste \ couldn't taste anything), ANOSMIA (started losing sense of smell), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASOPHARYNGITIS (Had a cold) and DECREASED APPETITE (lost his appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Peripheral swelling
Clinical narrative: swelling in arm; pain for a day; a little fatigue for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS, ALENDRONATE SODIUM (FOSAMAX) and DOXYCYCLINE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 02-Apr-2021, PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication reported includes ADVIL.   This case was linked to MOD21-082758 (E2B Linked Report).; Sender's Comments:  MOD21-082758:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Burning sensation, Chills, Dyspnoea, Headache
Clinical narrative: Could not sleep the whole night; Little difficulty in breathing; Whole body pain; Lips and cheeks burning; Lips and cheeks burning; Difficulty talking; Headache; Chills; Nausea but couldn't vomit; Temp 101; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning) and BURNING SENSATION (Lips and cheeks burning) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN and GLYBURIDE for Diabetes mellitus.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101). At the time of the report, INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Body temperature: 101 (High) High. On 26-Apr-2021, Oxygen saturation: 96 (normal) normal.         Treatment information was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Oral discomfort, Oxygen saturation, Pain
Clinical narrative: Could not sleep the whole night; Little difficulty in breathing; Whole body pain; Lips and cheeks burning; Lips and cheeks burning; Difficulty talking; Headache; Chills; Nausea but couldn't vomit; Temp 101; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning) and BURNING SENSATION (Lips and cheeks burning) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN and GLYBURIDE for Diabetes mellitus.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101). At the time of the report, INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Body temperature: 101 (High) High. On 26-Apr-2021, Oxygen saturation: 96 (normal) normal.         Treatment information was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Speech disorder
Clinical narrative: Could not sleep the whole night; Little difficulty in breathing; Whole body pain; Lips and cheeks burning; Lips and cheeks burning; Difficulty talking; Headache; Chills; Nausea but couldn't vomit; Temp 101; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning) and BURNING SENSATION (Lips and cheeks burning) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Diabetic. Concomitant products included METFORMIN and GLYBURIDE for Diabetes mellitus.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101). At the time of the report, INSOMNIA (Could not sleep the whole night), DYSPNOEA (Little difficulty in breathing), PAIN (Whole body pain), ORAL DISCOMFORT (Lips and cheeks burning), BURNING SENSATION (Lips and cheeks burning), SPEECH DISORDER (Difficulty talking), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea but couldn't vomit) and PYREXIA (Temp 101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2021, Body temperature: 101 (High) High. On 26-Apr-2021, Oxygen saturation: 96 (normal) normal.         Treatment information was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: feeling under the weather; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feeling under the weather) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (feeling under the weather). At the time of the report, VACCINATION COMPLICATION (feeling under the weather) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Sore arm after 2nd dose; Fever after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after 2nd dose) and PYREXIA (Fever after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm after 2nd dose) and PYREXIA (Fever after 2nd dose). At the time of the report, PAIN IN EXTREMITY (Sore arm after 2nd dose) and PYREXIA (Fever after 2nd dose) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant details were provided No treatment details were provided     This case was linked to MOD-2021-020171.